Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum

By sjmartinez • January 6, 2024

Hoffman RM, Brummel S, Ziemba L, Chinula L, McCarthy K, Fairlie L, Jean-Philippe P, Chakhtoura N, Johnston B, Krotje C, Nematadzira TG, Nakayiwa F, Ndyanabangi V, Hanley S, Theron G, Violari A, João E, Correa Junior MD, Hofer CB, Navanukroh O, Aurpibul L, Nevrekar N, Zash R, Shapiro R, Stringer JSA, Currier JS, Sax P, Lockman S; IMPAACT 2010/VESTED Study Team. Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum. Clin Infect Dis. 2024 Jan 5:ciae001. doi: 10.1093/cid/ciae001. Epub ahead of print. PMID: 38180851.

Tags: adverse pregnancy outcomes, antepartum weight change, HIV, Infectious Diseases, postpartum weight, Publications, Women’s health

Impacts of neutralizing antibody responses on SARS-CoV-2 evolution and its associated disease progression

Wang L, Aliyari S, Sands N, Lee B, Yu A, Xia S, Jolkovsky EL, Zhang S, Kim J, Cheng G. Impacts of neutralizing antibody responses[...]

High HBV Seroprotection Rates in Infants Born to People with HIV and HBV Infection in Sub-Saharan Africa

Mohtashemi N, Spaczai J, Guo R, Tseng CH, Cambou MC, Emel L, Ship H, Zhang TH, Chiu SH, Stranix-Chibanda L, Chipato T, Kintu K, Manji[...]

Centering the voices of transwomen in HIV prevention

Clark J, Caceres C. Centering the voices of transwomen in HIV prevention. AIDS. 2025 Nov 15;39(14):2138-2139. doi: 10.1097/QAD.0000000000004354. Epub 2025 Oct 30. PMID: 41603875.